Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Normal saline (0.9% sodium chloride solution) is used as a placebo control in a randomized, double-blind clinical trial conducted by the Medical University of South Carolina. The trial, titled "Low Dose Vasopressin for Renal Protection During Liver Transplantation," evaluates whether a low-dose vasopressin infusion can preserve kidney function in patients undergoing liver transplant surgery. In this study, the normal saline placebo is administered via an internal jugular catheter at a rate of 6.25 mL/hr, matching the infusion rate of the active vasopressin arm to maintain blinding. It serves as an inert comparator to assess the efficacy of vasopressin in preventing post-operative renal failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on normal saline placebo (Medical University of South Carolina).